Á¦3ȸ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ °áÇÙ¿¬±¸È¸ ±¹Á¦ ½ÉÆ÷Áö¾ö : 2023-10-28
±³À°ÀÏÀÚ : 2023-10-28
±³À°Àå¼Ò : ¼¿ï´ëÇб³º´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ 1Ãþ ¼¼ºÈ¯ ¿¬±¸È¦
±³À°ÁÖÁ¦ : Á¦3ȸ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ °áÇÙ¿¬±¸È¸ ±¹Á¦ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : °áÇÙ¿¬±¸È¸
´ã´çÀÚ : ±è½ÃÀ±
¿¬¶ôó : 02-575-3825
À̸ÞÀÏ : katrd@hanmail.net
±³À°Á¾·ù : ³»°ú, ÀÇ»çÇÐ, ÀÇÇб³À°
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í ÇöÀåµî·Ï 20,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 28ÀÏ 13:30~14:10 Environmental Epidemiology of NTM – Evidence for Different Sources of NTM and Links to Human Infection, Geospatial Epidemiology and Links with Climate and Other Variables Rachel Thomson(University of Queensland, Australia)
±³À°½Ã°£ 10¿ù 28ÀÏ 14:10~14:40 Cross-transmission of Nontuberculous Mycobacteria among Patients with or without Cystic Fibrosis Á¶°æ¿í(¿ï»êÀÇ´ë ³»°ú)
±³À°½Ã°£ 10¿ù 28ÀÏ 14:50~15:20 Approaches for Rarely Isolated Non-Tuberculous Mycobacteria Infections °¿µ¾Ö(¿¬¼¼ÀÇ´ë ³»°ú)
±³À°½Ã°£ 10¿ù 28ÀÏ 15:20~15:50 Alternative Treatment Goal for Nontuberculous Mycobacterial Pulmonary Disease: Focus on Improving Health-Related Quality of Life °û³«¿ø(¼¿ïÀÇ´ë ³»°ú)
±³À°½Ã°£ 10¿ù 28ÀÏ 16:00~16:30 Cutting-Edge Treatment Approaches for M. avium Complex and M. abscessus Pulmonary Diseases Àüº´¿ì(¼º±Õ°üÀÇ´ë ³»°ú)
±³À°½Ã°£ 10¿ù 28ÀÏ 16:30~17:10 Host Directed Therapies for NTM – inhaled GM-CSF and Nitric Oxide Trials Rachel Thomson(University of Queensland, Australia)